PULIKE BIOLOGICAL ENGINEERING，INC. revenue for the last year amounted to 1.23 B CNY, the most of which — 461.60 M CNY — came from its highest performing source at the moment, Pig Vaccines, the year earlier bringing 387.90 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought PULIKE BIOLOGICAL ENGINEERING，INC. 1.20 B CNY, and the year before that — 1.07 B CNY.